IL18 and COVID-19: Overall, these findings suggest that neutrophils may lose the ability to secrete IL-18 in response to inflammasome activity during maturation, and increased release of neutrophil-derived IL-18 occurs primarily in disease states associated with extensive granulopoiesis and increased immature granulocyte counts in the blood, like COVID-19 [38].